University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments
Status: Red Guanfacine (Intuniv®)

2nd line Atomoxetine, hospitals to manage/support patient. For the treatment of ADHD in children and adolescents 6-17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.

Status: Red Guselkumab
Status: Grey Guselkumab (Tremfya®)

Please contact mmag@uhb.nhs.uk for advice

Status: Red Haem arginate (Normasang)

NHSE commissioned.

Status: Green Haemophilus Type B Minigococcal Group C Conjugate vaccine (Menitorix®)

Supported with PGD

Status: Green Haleraid®
Status: Amber Haloperidol
Status: Amber Haloperidol capsules

ESCA

Status: Amber Haloperidol decanoate injection

Specialist initiation only

Status: Amber Haloperidol injection
Building healthier lives
Back to top